UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 23, 2018

 

CONVERSION LABS, INC.

 (Exact name of registrant as specified in its charter)

 

Delaware   333-184487   76-0238453
(State or other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1460 Broadway

New York, NY

  10036
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 866-351-5907

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company      ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

 

 

 

 

 

 

Item 1.01. Entry Into a Material Definitive Agreement

 

On July 23, 2018, Conversion Labs, Inc. (the “Company”) entered into an Amended and Restated Operating Agreement of Conversion Labs PR LLC (formerly “Immudyne PR LLC”) (“Conversion Labs PR”), the Company’s majority owned subsidiary (the “Amended Operating Agreement”). Amendments to the Amended Operating Agreement were made specifically to (i) correct existing ambiguities in the Amended Operating Agreement; and (ii) to define the preferred equity interest to be issued to Mr. Sean Fitzpatrick by Conversion Labs PR in connection with his appointment as the Company’s Chief Acquisition Officer.

 

The foregoing description of the Amended Operating Agreement does not purport to be complete and is qualified in its entirety by its full text which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors, Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Chief Acquisition Officer and Compensatory Arrangements

 

On October 25, 2018, the Board of Directors (the “Board”) of the Company ratified the appointment of Mr. Sean Fitzpatrick as the Company’s Chief Acquisition Officer (“CAO”) and approved the Company’s entrance into an employment agreement with Mr. Fitzpatrick (the “Fitzpatrick Employment Agreement”).

 

Mr. Fitzpatrick is currently the President of LegalSimpli Software LLC (“LSS”), a majority owned subsidiary of the Conversion Labs PR.

 

Mr. Fitzpatrick, age 35, combines over 10 years of experience in marketing with a strategic approach to margin optimization following a career in bankruptcy law. Previously, he had been involved in ten companies holding positions including Head of Customer Acquisition and Senior Director of Marketing and adviser to SEO Radar. From 2014 through 2018, Mr. Fitzpatrick was the Head of Customer Acquisition for BOLD PR LLC, an online technology company in the competitive career space. From 2008 to 20018, he was a consultant of multiple companies including Reply! Inc., YouCaring LLC (now part of GoFundMe) and Jolly Technology Inc. Mr. Fitzpatrick has an undergraduate degree from University of California, Santa Cruz, a Juris Doctor from Santa Clara University, School of Law, and is an active member of the California Bar Association in good standing.

 

There is no arrangement or understanding between Mr. Fitzpatrick and any other persons pursuant to which Mr. Fitzpatrick was selected as an officer. There are no family relationships between Mr. Fitzpatrick and any director, executive officer or person nominated or chosen by the Company to become a director or executive officer of the Company within the meaning of Item 401(d) of Regulation S-K under the U.S. Securities Act of 1933 (“Regulation S-K”). Since the beginning of the Company’s last fiscal year, the Company has not engaged in any transaction in which Mr. Fitzpatrick had a direct or indirect material interest within the meaning of Item 404(a) of Regulation S-K.

 

Pursuant to the Fitzpatrick Employment Agreement, by and between the Company, Conversion Labs PR and Mr. Fitzpatrick, Mr. Fitzpatrick will receive an annual base salary of Seventy-Two Thousand Dollars ($72,000) (the “Base Salary”). Mr. Fitzpatrick will receive from Conversion Labs PR a preferred equity interest issued by Conversion Labs PR which is equal to the lesser of 100% of the Qualifying Cash (as defined in the Amended Operating Agreement) available for distribution during any month and $6,000.00 subject to the terms of the Amended Operating Agreement (the “Equity Interest”).

 

The Equity Interest is not payable by the Company and will not be reflected in the Company’s books and records. In addition, Mr. Fitzpatrick will be eligible for a performance based bonus payable in cash is to be determined within the first ninety (90) days of Fitzpatrick’s employment.

 

As a full-time employee of the Company, Mr. Fitzpatrick will be eligible to participate in all of the Company’s benefit programs.

 

The Company or Mr. Fitzpatrick may terminate the employment of Mr. Fitzpatrick at any time and for any reason, with or without notice. In the event of termination, Mr. Fitzpatrick shall be entitled to all option shares vested prior to the date of termination.

 

The Fitzpatrick Agreement is for a term of five (5) years commencing on July 23, 2018 (the “Term”).

 

The Company believes that Mr. Fitzpatrick may be a “Named Executive Officer” as defined by Item 402 of Regulation S-K during the fiscal year ended December 31, 2018.

 

Mr. Fitzpatrick will also receive a warrant (the “Fitzpatrick Warrant”) to purchase five million (5,000,000) shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), exercisable for a period of ten (10) years at an exercise price of $0.30 per share which vests pursuant to the vesting schedule contained in the Fitzpatrick Warrant.

 

The foregoing description of the Fitzpatrick Agreement and Fitzpatrick Warrant do not purport to be complete and are qualified in their entirety by the full text of which are filed as Exhibit 10.2 and 10.3, respectively, hereto and are incorporated herein by reference.

 

  1  

 

 

Item 8.01 Other Events

 

On July 25, 2018, the Company issued a press release announcing the appointment of Mr. Fitzpatrick as the CAO. A copy of the press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.

 

On July 23, 2018, Immudyne PR LLC, filed a Certificate of Amendment (“Certificate of Amendment”) with the Government of Puerto Rico to change its name to Conversion Labs PR LLC. A copy of the (“Certificate of Amendment”) is filed hereto as Exhibit 99.2 and is incorporated herein by reference.

 

Item 9.01. Exhibits.

 

(d) Exhibits

 

Exhibit No.   Exhibit
     
10.1*  

Amended and Restated Operating Agreement of Immudyne PR LLC

     
10.2*   Employment Agreement by and between the Company and Mr. Sean Fitzpatrick, dated July 23, 2018
     
10.3*   Form of Fitzpatrick Warrant
   
99.1*   Press Release, dated July 25, 2018.
     
99.2*   Certificate of Amendment to Immudyne PR LLC

 

* Filed herewith

 

  2  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CONVERSION LABS, INC.
  (Registrant)
   
Date: October 29, 2018 By: /s/ Justin Schreiber
  Name: Justin Schreiber
  Title: Chief Executive Officer

  

  3  

Exhibit 10.1

 

AMENDED AND RESTATED LIMITED LIABILITY COMPANY

OPERATING AGREEMENT

OF

 

IMMUDYNE PR LLC
(a Puerto Rico limited liability company)

 

THIS AMENDED AND RESTATED LIMITED LIABILITY COMPANY OPERATING AGREEMENT (this “ Agreement ”) of IMMUDYNE PR LLC (the “ Company ”), a Puerto Rico limited liability company, dated as of July [●], 2018 (the “ Effective Date ”), is made by and among the persons set forth on Schedule A attached hereto (each individually referred to as a “ Member ” and, collectively, together with any additional members hereafter admitted to the Company in accordance with the provisions of this Agreement, as the “ Members ”).

 

RECITALS:

 

WHEREAS , the Company was organized on January 20, 2016 by filing on said date a Certificate of Formation with the Secretary of State of the Commonwealth of Puerto Rico;

 

WHEREAS , on April 1, 2016, the Members listed on Schedule A of the Original Agreement (the “ Initial Members ”) executed a certain Limited Liability Company Operating Agreement (the “ Original Agreement ”) to provide for the operation of the Company; and

 

WHEREAS , the Members desire to execute this Agreement in order to amend and restate in its entirety the Original Agreement, and to set forth all of the provisions for the governance of the affairs and the conduct of the business of the Company and the respective rights and obligations of each Member.

 

NOW, THEREFORE , in consideration of the covenants herein contained and other valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

Article 1
FORMATION, PURPOSE AND DEFINITIONS

 

1.1 Establishment of Limited Liability Company . The Members hereby agree to establish and organize a Puerto Rico limited liability company upon the terms set forth in this Agreement. The Members are hereby admitted to membership in the Company.

 

1.2 Name . Pursuant to the terms of this Agreement, the Members intend to carry on a business for profit under the name ImmuDyne PR LLC . The Company may conduct its activities under any other permissible name designated by the Members. The Members shall be responsible for complying with any registration requirements in the event an alternative name is used.

 

1

 

 

1.3 Offices and Registered Agent . The principal place of business of the Company shall be located at 53 Calle Palmeras, Suite 802, San Juan, PR 00901, or at such other location as the Members may determine. The Company may have any number of other offices at such locations as the Members may determine. The registered agent for the service of process and the registered office of the Company shall be the person and location set forth in the Company’s Certificate of Formation filed with the Office of the Secretary of Commonwealth of Puerto Rico. The Members may, from time to time, change such registered agent and registered office by appropriate filings as required by law.

 

1.4 Purpose . The Company’s purpose shall be to operate as an international trade hub based in Puerto Rico, where it will (i) coordinate the transfer, sale and resale of proprietary immune support products (the “Products”); (ii) provide call-center services for advertising, client support and marketing in connection with the Products; (iii) provide centralized management services involving logistics, accounting, and other managerial services for the Company’s international operations; and (iv) engage in any other lawful business for which limited liability companies may be organized under the Act. The Company shall have the authority to do all things necessary or advisable in order to accomplish such purposes.

 

1.5 Duration . Unless the Company shall be earlier terminated in accordance with Article 6 , the Company shall continue in existence in perpetuity.

 

1.6 Other Activities of Members . The Members may engage in or possess an interest in other business ventures of any nature, but Taggart International Trust and American Nutra Tech LLC and their respective principals, may not engage directly or indirectly in activities in direct competition with the activities of the Company.

 

1.7 Federal Income Tax Status . The Company is intended to qualify to be treated for US federal income tax purposes as a corporation.

 

Article 2
CAPITAL MATTERS

 

2.1 Members . The names and addresses of the Members are contained in Schedule A attached to this Agreement.

 

2.2 Membership Units . The Company is hereby authorized to and does issue units (“ Membership Units ”) in exchange for each Member’s Capital Contribution, in the amount set forth on Schedule B . The Units shall be divided into three classes: (i) Class A Common Units, (ii) Class B Common Units, and (iii) Class C Common Units.

 

2.3 Capital Contributions . The initial capital account balances of the Members are set forth on Schedule A and reflect the cash or property contributed by each Member as shown thereon. No interest shall accrue on any capital contributions, and no Member shall have the right to withdraw or to be repaid, any capital contributed by such Member, except as and to the extent specifically provided in this Agreement.

 

2

 

 

2.4 Additional Capital Contributions . If the Members unanimously determine that the Company requires additional capital contributions from the Members, then written notice thereof shall promptly be given to all Members. Upon the date specified in such notice, which date shall not be less than fifteen (15) days after the date such notice is delivered, the Members shall deliver to the Company in cash their pro rata share, based on their respective Membership Units, of the total amount of additional capital required by the Company.

 

2.5 Authorization of Preferred Equity Interests .

 

(a) In consideration of services rendered to or for the benefit of the Company, the Members may, from time to time, issue units of preferred, non-voting, equity interests in the Company (“Preferred Equity Units”). The recipient of any Preferred Equity Unit (a “Preferred Equity Member”) shall execute the Preferred Equity Rider in the form of Schedule C . A Preferred Equity Unit shall entitle the corresponding Preferred Equity Member to the Preferred Equity Interest. Preferred Equity Members shall not be considered “Members” of the Company and shall have no right or power to vote on, consent to, or approve any matters relating to the Company. Preferred Equity Members shall have no right to access, inspect and use any information or records of the Company. Preferred Equity Members shall have only those rights, duties and powers, if any, set forth in the Preferred Equity Rider. Except as otherwise provided in this Agreement, the rights, limitations, and restrictions on transfers and encumbrance of Preferred Equity Interests will only be determined under the Preferred Equity Rider. The Company shall only have those buy-back, call back, and similar rights regarding Preferred Equity Interests as may be set forth in the Preferred Equity Rider.

 

(b) The Preferred Equity Members are the persons listed on Schedule C as executing the Preferred Equity Rider as of the date set forth therein. Contemporaneously with the execution of the Preferred Equity Rider, the Company has issued to the Preferred Equity Member the number of Preferred Equity Units set forth in Schedule C.

 

i. The term “Preferred Equity Interest” means the right of a Preferred Equity Member to receive distributions of Qualifying Cash, as defined in Article 3.1 of this Agreement, pursuant to this Agreement and the terms and conditions set forth in the Preferred Equity Rider, but not including any right to participate in the management or affairs of the Company, such as the right to vote, inspect and use Company information and records, or otherwise participate in any decision of the Members.

 

ii. The term “Preferred Equity Distribution” shall have the meaning given to such term in the Preferred Equity Rider.

 

iii. The term “Preferred Equity Rider” means the terms and conditions set forth in Schedule C attached hereto describing the Preferred Equity Interest and setting forth the rights and duties of a Preferred Equity Member.

 

2.6 Transferred Capital Accounts; Adjustments . Upon the transfer of all or any part of a Membership Interest, the Capital Account of the transferor Member that is attributable to the transferred interest shall carry over to the transferee Member.

 

3

 

 

2.7 Return of Capital . Each Member is entitled to the return of such Member’s contribution only by way of distributions made pursuant to Article 3 or Article 6 . No Member shall have the right to receive any property other than cash in return for such Member’s capital contribution or to bring an action of partition against the Company or its property.

 

2.8 Loans . If a Member makes any loan to the Company, or advances money on its behalf, the amount of any such loan or advance shall not be deemed an increase in, or contribution to, the capital of the Company. Interest shall accrue on any such loan or advance at an annual rate agreed to by the Member making such loan to the Company and the other Members (but not in excess of the maximum rate allowable under applicable usury laws).

 

2.9 Additional Members . The Members shall have the right to admit new Members to the Company upon the approval of all the Members and the contribution of cash or other assets, including in connection with a merger transaction and upon the execution of such agreements as the Members may deem advisable; provided that (i) the Members conclude that such additional Member may be legally admitted without violating applicable federal and state securities laws and (ii) such transfer will not cause the Company to be treated as an association taxable as a corporation or otherwise to be taxed as an entity for federal income tax purposes. Any Person (as hereinafter defined) so admitted as a Member shall have all of the rights, privileges and obligations of a Member as if an original signatory to this Agreement. The term “Person” means an individual, corporation, partnership, limited liability company, trust, estate, joint stock company or other entity of whatever nature.

 

2.10 Limitation of Liability of Members . No Member shall have any liability or obligation for any debts, liabilities or obligations of the Company, or of any agent or employee of the Company, beyond the Member’s capital contribution, except as may be expressly required by this Agreement or applicable law.

 

Article 3
DISTRIBUTIONS AND ALLOCATIONS

 

3.1 Distributions .

 

(a) From time to time (but at least once each calendar quarter) the Members shall cause the Company to distribute cash from Qualifying Cash, as defined below, in the following manner:

 

first , to the Preferred Equity Members to pay the Preferred Equity Distribution; and

 

second , the remaining Qualifying Cash shall be distributed to each class of Membership Units (excluding Preferred Equity Units) in proportion to the equity percentage that such class represents of the total Membership Units of the Company as specified on Schedule B attached hereto, reduced by any actual distributions made during the year.

 

i. The term “Qualifying Cash” means, for each calendar year, cash available for distribution by the Company after payment of current expenses and liabilities of the Company (including any withholding obligations except as provided in Article 3.1(b) ); provided however , that the term “Qualifying Cash” shall not include non-cash assets of the Company that is distributed, or is available for distribution, to the Members, unless the distribution of such non-cash assets is due to the liquidation or dissolution of the Company.

 

4

 

 

ii. To the extent any particular class of Membership Units does not receive its corresponding distribution during the year in question (the “Accumulated Undistributed Amount”), the Company shall segregate such class’ Accumulated Undistributed Amount into a separate account. The Accumulated Undistributed Amount shall be considered Qualifying Cash only with respect to the applicable class to which no distribution was made during the year.

 

iii. If upon the distribution referred to in Article 3.1(a), there is any Accumulated Undistributed Amount with respect to a particular class of Membership Units, the cash distributions shall first be made to cover the particular class of Membership Units’ Accumulated Undistributed Amount, with any excess Qualifying Cash being distributed pro-rata among the different classes of Membership Units.

 

(b) Any income or other taxes required to be paid to any taxing authority by the Company on account of any Member’s share of any Company property, income, or gain, or out of any Company distribution to any Member, shall be treated as having been distributed to that Member and offset against such Member’s right to current (and, if necessary, future) distributions from the Company.

 

Article 4
ADMINISTRATIVE MATTERS

 

4.1 Meeting of Members .

 

(a) Place of Meetings . All meetings of the Members shall be held at such place or places, within or outside the Commonwealth of Puerto Rico, as shall be determined by a majority of the vote from time to time or by means of the Internet or other electronic communications technology in a fashion pursuant to which the Members have the opportunity to read or hear the proceedings substantially concurrently with their occurrence and vote on matters submitted to the Members.

 

(b) Annual Meetings . At least once in each calendar year on a date determined by a majority of the vote, a meeting of the Members shall be held to transact such business as may properly be brought before the meeting.

 

(c) Special Meetings . Special meetings of the Members may be called at any time by a majority of the vote. At any time, upon written request of any person who has called a special meeting, it shall be the duty of the Secretary of the Company to fix the time of the meeting which shall be held not more than fifteen (15) days after the request for a special meeting. If the Secretary shall neglect or refuse to fix the date and give notice, the Member making the request may do so.

 

5

 

 

(d) Notice of Meetings . Written notice of every meeting of Members, stating the time and geographic location thereof, if any, shall be given (by, or at the direction of, the party authorized to call the meeting) to each Member of record entitled to vote at the meeting at the address appearing on the records of the Company or supplied by the Member to the Company for the purpose of notice, at least five (5) days prior to the day named for the meeting, unless a greater period of notice is required by statute in a particular case. In the case of a special meeting of Members, the notice shall also set forth the purpose of the meeting. When a meeting is adjourned, it shall not be necessary to give any notice of the adjourned meeting or of the business to be transacted at any adjourned meeting, other than by announcement at the meeting at which such adjournment is taken.

 

(e) Quorum . The Members present, in person, by proxy or by means of electronic technology, including, without limitation, the Internet, at a Members’ meeting duly called, who are entitled to cast a majority of the vote that all Members are entitled to cast on a particular matter at any such meeting, shall constitute a quorum for the transaction of business except as otherwise provided by law or by resolution of the Members prior to such meeting. If however, such quorum shall not be present, those present thereat may adjourn the meeting to such time and place as they may determine.

 

(f) Actions by Members . Except as otherwise expressly provided in this Agreement, the Members shall act by a majority of the vote, as such term is defined in Article 4.1(g), of the holders of the Membership Units.

 

(g) Voting . The classes of Membership Units shall be entitled to a vote, in person or by proxy, in accordance with the voting percentages set forth on Schedule B attached hereto.

The term “majority” or “majority of the vote” shall mean more than fifty percent (50%).

 

(h) Proxy Voting . At each meeting of the Members every Member having the right to vote shall be entitled to vote in person or by proxy appointed by an instrument in writing subscribed by such Member and delivered to the Secretary at the meeting. No unrevoked proxy shall be valid after eleven (11) months from the date of its execution, unless a longer time is expressly provided therein.

 

(i) Voting List . The officer or agent of the Company having charge of the transfer books shall make, at least five (5) days before each meeting of Members, a complete list of the Members entitled to vote at the meeting, arranged in alphabetical order, with the address of and the Membership Units held by each, which list shall be kept on file at the place of business of the Company, and shall be subject to inspection by any Member at any time during usual business hours. Such list shall also be produced and kept open at the time and place of the meeting, and shall be subject to the inspection of any Member during the whole time of the meeting.

 

(j) Informal Action by Unanimous Consent . Any action required or permitted to be taken at a meeting of the Members may be taken without a meeting if a consent or consents, setting forth the action so taken, shall be given by a majority of the vote of the Members who would be entitled to vote at a meeting for such purpose and shall be filed with the Secretary of the Company.

 

6

 

 

(k) Participation in Meetings via Telephone or other Electronic Means . Members may participate in any meeting of the Members by conference telephone, similar communications equipment or other electronic means, including without limitation, the internet. Members so participating will be deemed present at the meeting.

 

4.2 Management . The business and affairs of the Company shall be managed by the Members.

 

4.3 Appointment of Officers and Agents .

 

(a) The officers of the Company (the “Officers” ) shall be designated by a majority vote of the Members and shall include at least a president (the “ President ”), a Chief Executive officer (the “ Chief Executive Officer ”), a Chief Operating Officer (the “COO”) and the Secretary (the “ Secretary ”). The respective duties of President, Chief Executive Officer and Secretary are as described in Schedule D . Any Officer may delegate to one or more persons any administrative duties, under and subject to such Officer’s supervision and direction. The following initial officers are hereby appointed and shall serve until their successors have been duly appointed:

 

Stefan Galluppi Chief Executive Office, President and Secretary Justin Schreiber

 

Mark McLaughlin Chief Operating Officer and Treasurer Stefan Galluppi

 

(b) The Members may designate such other Officers and agents as they shall deem necessary or advisable who shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the Members. The salaries and/or reimbursements of expenses, if any, of all Officers and agents of the Company shall be fixed by a majority of the vote of the Members. The Officers of the Company shall hold office until their successors are chosen and qualified. Any Officer may be removed at any time, with or without cause, by the affirmative vote of the Members holding a majority of the vote of the Membership Units. Any vacancy occurring in any office of the Company shall be filled by the Members.

 

4.4 Officers as Agents . The Officers, to the extent of their powers set forth in this Agreement or otherwise vested in them by action of the Members not inconsistent with this Agreement, are agents of the Company for the purpose of the Company’s business and the actions of the Officers taken in accordance with such powers shall bind the Company. No officer shall bind the company for any expenditure and/or commitment valued in excess of $10,000 without express written authorization by Members holding a majority of the vote of the Membership Units.

 

4.5 Duties of Members and Officers . Each Member and Officer of the Company, shall be required to devote such amount of time to the Company as is necessary to satisfy the obligations of such Member or Officer to the Company. With the exception of compensation from ImmuDyne, Inc., Officers shall not receive compensation or remuneration from any suppliers, contractors, vendors or customers of the Company, except with the express written consent of Members holding a majority of the vote of the Membership Units.

 

7

 

 

4.6 Indemnification . Except as expressly prohibited by law, the Company shall indemnify, defend and hold harmless each Member and its beneficiaries and each Officer (each an “ Indemnified Party ”) from and against any and all debts, losses, claims, damages, costs, demands, fines, judgments, contracts (implied and expressed, written and unwritten), penalties, obligations, payments, and liabilities of every type and nature (whether known or unknown, fixed or contingent), including, without limitation, those arising out of any lawsuit, action or proceeding brought by or on behalf of a third party (each a “ Claim ”), together with any reasonable costs and expenses (including, without limitation, reasonable attorneys’ fees, out-of-pocket expenses and other reasonable costs and expenses incurred in investigating, preparing or defending any pending or threatened lawsuit, action or proceeding) incurred in connection with the foregoing suffered or sustained by such Indemnified Party by reason of any act, omission or alleged act or omission by such Indemnified Party arising out of such Indemnified Party’s activities taken primarily on behalf of the Company, or at the request or with the approval of the Company, or primarily in furtherance of the interests of the Company. Notwithstanding the foregoing, indemnification shall not be available under this Article 4.6 where (a) the acts, omissions or alleged acts or omissions upon which an actual or threatened action, proceeding or claim is based constituted willful misconduct or recklessness on the part of the person seeking indemnification, (b) the Indemnified Party fails to promptly notify the Members and the Officers of the Company (collectively referred to as the “ Representatives ”) of any Claim, or threat thereof, promptly after receiving notice thereof and within a reasonable time before a response to such Claim is required to be filed, or (c) if requested by one of the Representatives, the Indemnified Party fails to permit the Company to take over the defense of such Claim with counsel of its choosing or to fully cooperate to the fullest extent possible with the Company and its designated counsel in the defense of such claim.

 

4.7 Limitation of Liability . Except as expressly prohibited by law, each Member and its beneficiaries and each Officer (each a “ Released Party ”) shall not be liable, responsible or accountable in damages or otherwise to the Company or to any other Member for any act performed by the Released Party within the scope of the authority conferred on it (or them) by this Agreement or for its (or their) failure or refusal to perform any acts, so long as the Released Party acted without willful misconduct or recklessness.

 

Article 5
TRANSFER OF MEMBERSHIP UNITS

 

5.1 Transfer of Interests .

 

(a) General Restriction on Transfers . Except as otherwise expressly provided in this Agreement, no Member may Transfer (as hereinafter defined), whether voluntarily or involuntarily, any portion of such Member’s Membership Units without the prior written consent of all of the other Members. For purposes of this Agreement, a “ Transfer ” includes, but is not limited to, any voluntary or involuntary sale, assignment, gift, exchange, hypothecation, collateral assignment, pledge, transfer or subjection to any security interest.

 

8

 

 

(b) Permitted Transfer by Members . Notwithstanding Section 5.1(a) above, a Member may Transfer such Member’s Membership Interest, during lifetime or at death, in whole or in part, to and only to a Family Member (as hereinafter defined) (each, a “ Permitted Transferee ”). For purposes of this Agreement, “Family Member” means (i) any descendant, step-descendant and spouse of a Member, (ii) any trust for the benefit of one or more of the individuals referred to in clause (i), above, (iii) any custodianship under any Uniform Gifts or Transfers to Minors Act for an individual referred to in clause (i) above, (iv) the personal representative of a deceased individual referred to in clause (i), and (v) upon the approval of the holders of a majority of the vote of the Membership Units, a corporation, a limited liability partnership or a limited liability company all of the shares or interests of which are owned by one or more of the individuals or organizations referred to in clauses (i) through (iii), above. Any person who is adopted, regardless of the person's age at the time of the adoption, shall be deemed a natural child of his or her adopting parent or parents.

 

(c) Other Restrictions on Transfers . No Transfer of a Member’s Membership Units shall be made pursuant to Section 5.1(b) if, in the opinion of counsel to the Company, such assignment (i) may not be effected without registration under the Securities Act of 1933, as amended; (the “ Securities Act ”), (ii) does not satisfy an exemption under the Securities Act or (iii) would result in the violation of any applicable Federal or state securities laws. The Company shall not be required to recognize any Transfer of a Member’s Membership Units until the instrument conveying such interest has been delivered to the Company for recordation on the books of the Company. Unless a transferee becomes a substituted Member in accordance with Section 5.2 , he, she or it shall not be entitled to any of the rights granted to a Member hereunder, other than the economic benefits, including but not limited to the right to receive all or part of the share of the cash distributions or returns of capital to which his, her or its transferor would otherwise be entitled.

 

5.2 Substituted Members and Assignment of Membership Interest . A Permitted Transferee or other assignee, as consented to by the Members in accordance with Section 5.1(a) , of a Membership Unit shall become a Member in the place of the transferor (or in addition to the transferor, as the case may be) if and only if the transferee accepts and adopts in writing all of the terms and provisions of this Agreement, as the same may have been amended. In such event, the distribution ratio set forth in Sections 3.3 and 6.2(c) shall be amended accordingly.

 

5.3 Obligation of Transferring Member . Except as otherwise agreed to by all of the Members, no transfer by a Member of such Member’s Membership Units shall, to any extent, relieve the transferring Member of any of such Member’s obligations to the Company or liability, if any, as a Member.

 

Article 6
DISSOLUTION AND LIQUIDATION

 

6.1 Events Triggering Dissolution . The Company shall dissolve and commence winding up and liquidating upon the first to occur of any of the following (“ Liquidating Events ”):

 

(a) majority of the vote; and

 

(b) entry of a decree of judicial dissolution pursuant to the Act.

 

9

 

 

The Company shall not be dissolved for any other reason, including without limitation, a Member’s becoming bankrupt or executing an assignment for the benefit of creditors and any such bankruptcy or assignment shall not effect a transfer of any portion of a Member’s Membership Units in the Company.

 

6.2 Liquidation . Upon a Liquidating Event of the Company in accordance with Section 6.1 , the Company shall be wound up and liquidated by the Members or by a liquidating manager selected by the Members. The proceeds of such liquidation shall be applied and distributed in the following order of priority:

 

(a) to creditors, including any Member who is a creditor, in the order of priority as established by law, in satisfaction of liabilities of the Company (whether by payment or the making of reasonable provision for payment thereof) other than liabilities for which reasonable provision for payment has been made and liabilities for distributions to the Members as provided by the Act; and then

 

(b) to the setting-up of any reserves in such amount and for such period as shall be necessary to make reasonable provisions for payment of all contingent, conditional or unmatured claims and obligations known to the Company and all claims and obligations known to the Company but for which the identity of the claimant is unknown; and then

 

(c) to the Members, which liquidating distribution shall be made to each class of Membership Units, in proportion to the equity percentage that such class represents of the total Membership Units of the Company, as specified on Schedule B attached hereto, in cash or in kind, or partly in cash and partly in kind, as the Members may vote.

 

6.3 Certificate of Dissolution . Upon the dissolution of the Company and the completion of the liquidation and winding-up of the Company’s affairs and business, the Members shall, on behalf of the Company, prepare and file a Certificate of Dissolution with the Office of the Secretary of the State of the State of Delaware, as required by the Act. When such certificate is filed, the Company’s existence shall cease.

 

Article 7
ACCOUNTING AND FISCAL MATTERS

 

7.1 Fiscal Year . The fiscal year of the Company shall be the calendar year.

 

7.2 Method of Accounting . The President shall select a method of accounting for the Company as deemed necessary or advisable and shall keep, or cause to be kept, full and accurate records of all transactions of the Company in accordance with sound accounting principles consistently applied.

 

7.3 Financial Books and Records . All books of account shall, at all times, be maintained in the principal office of the Company or at such other location as specified by the Members so long such location is within Puerto Rico. Each member, or the Member’s designee, shall have full access to the financial books and records. Each member shall have the right to audit the financial books twice yearly.

 

10

 

 

7.4 Tax Matters Member . The Members shall appoint a Member to serve as the Tax Matters Member of the Company who shall have the duties and authority of a Tax Matters Partner as specified in the Code, as amended, and the regulations promulgated thereunder. The initial Tax Matters Member shall be Justin Schreiber.

 

Article 8
MISCELLANEOUS

 

8.1 Notices . All notices, requests, demands and other communications required or permitted under this Agreement shall be in writing (including email or other written electronic communication) and shall be deemed to have been duly given and made upon being delivered to the recipient party by email (with confirmation of receipt and opening), recognized courier service, fax transmission (with confirmation of receipt) for those parties having a fax number listed below or by registered or certified mail (postage prepaid, return receipt requested), and addressed to the applicable address set forth below or such other address as may be designated in writing hereafter by the recipient party in accordance with this Section 8.1 .

 

8.2 Binding Effect . Except as otherwise provided in this Agreement, this Agreement shall be binding upon and inure to the benefit of the Members and, subject to Article 5 , its successors and assigns.

 

8.3 Dispute Resolution; Mediation and Arbitration .

 

(a) In the event of any dispute arising under or pursuant to this Agreement, the Members agree to attempt to resolve the dispute in a commercially reasonable fashion before instituting any arbitration or litigation. If the Members are unable to resolve the dispute within thirty (30) days, then the Members agree to mediate the dispute with a mutually agreed upon mediator in New York. If the Members cannot agree upon a mediator within ten (10) days after either party shall first request commencement of mediation, each party will select a mediator within five (5) days thereof, and those mediators shall select the mediator to be used. The mediation shall be scheduled within thirty (30) days following the selection of the mediator. If the mediation does not resolve the dispute, then Paragraph 8.3(b) shall apply. The Members further agree that any applicable statute of limitations will be tolled for the period of time from the date mediation is requested until 14 days following the mediation.

 

(b) All disputes arising out of or relating to this Agreement which cannot be settled by the parties, other than claims solely for injunctive relief where time is of the essence, shall promptly be submitted to and determined in arbitration in Puerto Rico, pursuant to the commercial rules and regulations then in effect of the American Arbitration Association. The arbitrator(s) shall be elected as follows: in the event the Members agree on one arbitrator, the arbitration shall be conducted by such arbitrator. In the event the Members do not so agree, the Members on each side of the dispute shall select one independent, qualified arbitrator and the two arbitrators so selected shall select the third arbitrator. The decision of the arbitrator(s) shall be final and binding upon the parties and judgment upon such decision may be entered in any court of competent jurisdiction.

  

11

 

 

(c) Discovery shall be allowed pursuant to the United States Federal Rules of Civil Procedure and as the arbitrator(s) determine appropriate under the circumstances.

 

(c) Such arbitrator(s) shall be required to apply the contractual provisions hereof in deciding any matter submitted to them and shall not have any authority, by reason of this Agreement or otherwise, to render a decision that is contrary to the mutual intent of the parties as set forth in this Agreement.

 

8.4 Governing Law . This Agreement shall be governed by, and construed in accordance with, the laws of the Commonwealth of Puerto Rico without reference to conflict of laws principles.

 

8.5 Severability . The invalidity or unenforceability of any particular provision of this Agreement shall be construed in all respects as if such invalid or unenforceable provision were omitted.

 

8.6 Amendments . Except as otherwise specifically provided in the foregoing provisions of this Agreement, the provisions of this Agreement may be altered or amended only with the written consent of a majority of the vote of the Members.

 

8.7 Gender and Number . As used in this Agreement, the masculine gender shall include the feminine and neuter, and the singular shall include the plural, and vice versa.

 

8.8 Counterparts; Facsimile Signature . This Agreement may be executed in several counterparts, each of which shall be deemed an original, and all such counterparts shall constitute but one and the same instrument which may be sufficiently evidenced by one counterpart. This Agreement may be executed via facsimile or electronic signature, and each such facsimile copy, electronic signature or counterpart shall be deemed an original.

 

[Signature page follows]

 

12

 

 

IN WITNESS WHEREOF , and intending to be legally bound, the parties hereto have executed this Operating Agreement as of the date first set forth above.

 

  MEMBERS:
   
   
  Taggart International Trust
  By: Justin Schreiber
  Authorized Representative
   
   
  American Nutra Tech, LLC
  By: Stefan Galluppi
  Authorized Representative
   
   
  Conversion Labs, Inc.
  By: Justin Schreiber
  President & CEO

  

13

 

 

schedule a

 

LIMITED LIABILITY COMPANY OPERATING AGREEMENT

IMMUDYNE PR LLC

LISTING OF MEMBERS

 

As of the date first above written, following is a list of the Members of the Company:

 

NAME :

 

Taggart International Trust

Caribe Plaza Building, 8th Floor

53 Palmeras Street

San Juan, Puerto Rico 00901

 

American Nutra Tech LLC

Caribe Plaza Building, 8th Floor

53 Palmeras Street

San Juan, Puerto Rico 00901

 

Immudyne, Inc.

Address: 50 Spring Meadow Road

Mt. Kisco, NY 10549

 

A- 1

 

 

SCHEDULE B

 

LIMITED LIABILITY COMPANY OPERATING AGREEMENT

IMMUDYNE PR LLC

CAPITAL CONTRIBUTIONS

  

Members   Capital Contribution     Equity Percentage     Voting Percentage     Membership Units
Taggart International Trust   $ 30,000       11.3333 %     11.3333 %   1 Class A Common Unit
American Nutra Tech LLC   $ 30,000       10.5 %     10.5 %   1 Class B Common Unit
Conversion Labs, Inc.   $ 30,000       78.1667 %     78.1667 %   1 Class C Common Unit

 

B- 1

 

 

SCHEDULE C

 

PREFERRED EQUITY RIDER

 

TO

 

LIMITED LIABILITY COMPANY

OPERATING AGREEMENT

 

OF

 

IMMUDYNE PR LLC

 

THIS PREFERRED EQUITY RIDER TO AMENDED AND RESTATED LIMITED LIABILITY COMPANY OPERATING AGREEMENT OF IMMUDYNE PR LLC (the “ Preferred Equity Rider ”) is entered into and effective as of July 23, 2018 by and among those “ Preferred Equity Members ” whose signature appear on the signature page hereof and IMMUDYNE PR LLC (the “ Company ”), a limited liability company organized and existing under the laws of the Commonwealth of Puerto Rico.

 

WITNESSETH:

 

WHEREAS, the Amended and Restated Limited Liability Company Agreement of the Company dated as of July 23, 2018 (as amended, supplemented, amended and restated, or otherwise modified from time to time, the “ Operating Agreement ”; capitalized terms used herein but not otherwise defined shall have the definitions set forth in the Operating Agreement) authorizes the issuance by the Company and the granting of the Preferred Equity Interest to the Preferred Equity Members in consideration of services rendered to or for the benefit of the Company;

 

WHEREAS, the Operating Agreement provides that the rights, limitations, and restrictions of the Preferred Equity Interest, together with the rights and duties of the Preferred Equity Members, shall be set forth and determined in this Preferred Equity Rider; and

 

WHEREAS, by executing this Preferred Equity Rider, the Preferred Equity Members shall subscribe for the Preferred Equity Interest and shall agree to be bound by all of the terms and conditions set forth in the Operating Agreement (as applicable) and this Preferred Equity Rider.

 

NOW, THEREFORE, in consideration of these premises and the covenants and agreements set forth in this Preferred Equity Rider, the Company and the Preferred Equity Members agree as follows:

 

C- 1

 

 

Section 1. Grant of Preferred Equity Interest.

 

(a) Pursuant to the Operating Agreement and subject to the terms, conditions, limitations and restrictions set forth herein, the Company hereby allocates to the Preferred Equity Member one (1) Preferred Equity Unit as a preferred non-voting equity interest in the Company in consideration of services rendered to or for the benefit of the Company.

 

(b) The Preferred Equity Unit shall be fully vested and non-assessable and shall be registered in the name of the Preferred Equity Member on the books of the Company. The Preferred Equity Member shall not be required to make any contribution to the Company in exchange for the Preferred Equity Unit.

 

(c) The Preferred Equity Unit herein granted will have only those rights, restrictions and limitations as set forth herein. The parties hereto agree and acknowledge that the Company shall have the right to redeem the Preferred Equity Unit owned by the Preferred Equity Member at any time by paying to Preferred Equity Member a redemption price equal to the then accrued and unpaid Preferred Equity Distribution, if any.

 

(d) The Preferred Equity Member hereby agrees and acknowledges that the Preferred Equity Unit has been transferred to him based upon its relationship with the Company as its employee, officer or service provider. As a result, the Preferred Equity Member shall have no right to transfer the Preferred Equity Unit, either voluntarily or involuntarily, including but not limited to divorce, death or disability, or encumber or assign such Preferred Equity Unit to anyone else, and shall only have the right to retain these Preferred Equity Unit for as long as it is an employee, officer or other service provider of the Company.

 

(e) (i) Termination . Upon termination of the Preferred Equity Member’s employment or appointment with the Company for any reason, title to and ownership of the Preferred Equity Unit shall immediately and automatically revert back to the Company and the Preferred Equity Member shall be entitled to receive payment for such Preferred Equity Unit in an amount equal to the then accrued and unpaid Preferred Distribution, if any. Preferred Equity Member shall not be entitled to any Preferred Equity Distribution with respect thereto following the termination.

 

(ii) Death or Disability . If Preferred Equity Member’s employment or appointment with the Company ceases due to Preferred Equity Member’s death or disability, then the Preferred Equity Unit shall automatically revert to the Company and Preferred Equity Member (or Preferred Equity Member’s heirs in the event of Preferred Equity Member’s death) shall be entitled to receive payment for the Preferred Equity Unit in an amount equal to the then accrued and unpaid Preferred Equity Distribution, if any.

 

(iii) Divorce . In the event of Preferred Equity Member’s divorce, the Preferred Equity Unit shall automatically revert to the Company and Preferred Equity Member shall be entitled to receive a payment in the amount equal to the then accrued and unpaid Preferred Equity Distribution, if any. Preferred Equity Member’s spouse will at no time acquire any interest in the Preferred Equity Unit. Preferred Equity Member and his or her spouse shall indemnify the Company for any costs, losses or expenses that the Company may incur in connection with Preferred Equity Member’s failure to deliver the Preferred Equity Unit to the Company after Preferred Equity Member’s divorce.

 

C- 2

 

 

Section 2. Restrictions on Preferred Equity Interest; Preferred Equity Distribution.

 

(a) Restrictions on Preferred Equity Interest . The restrictions to which the Preferred Equity Interest shall be subject are:

 

(i) Preferred Equity Member and the Preferred Equity Unit will not have the right to vote and will not be counted in any decision that requires the vote of the Members for its approval. Preferred Equity Units will not bestow to the Preferred Equity Member any right to participate in the decisions or management of the Company. Preferred Equity Units will not bestow to the Preferred Equity Member any right to access the books and financial information of the Company.

 

(ii) Preferred Equity Units shall not have the right to participate in any liquidation of assets upon the dissolution of the Company.

 

(iii) None of such Preferred Equity Interest shall be sold, exchanged, transferred, pledged, hypothecated, or otherwise disposed of. If any attempt is made to sell, exchange, transfer, pledge, hypothecate, or otherwise dispose of any Preferred Equity Units held by the Preferred Equity Members, the Preferred Equity Interests that are the subject of such attempted disposition will be deemed forfeited by the Preferred Equity Member as of the date of such action, and the Company will repurchase them as described in Section 1(c) of this Preferred Equity Rider. Accordingly, any transfer, encumbrance or other disposition of the Preferred Equity Interest in violation of this Section 2(a)(iii) shall be null and void, and the other party to any such purported transaction shall not obtain any rights to or interest in the Preferred Equity Interest or Units.

 

(iv) The restrictions set forth in this Preferred Equity Rider and the Operating Agreement, with respect to the Preferred Equity Units, will not lapse. These restrictions will remain in effect until the Preferred Equity Units are forfeited by the Preferred Equity Member or bought back by the Company.

 

(b) Preferred Equity Interests Not Securities . The Preferred Equity Interests of the Preferred Equity Members in the Company and their Preferred Equity Units shall not constitute a “security” within the meaning of Article 8 of the Uniform Commercial Code, as in effect from time to time in each applicable jurisdiction (the “ UCC ”) and shall not be deemed a “security” for any purpose whatsoever of Article 8 or Article 9 of the UCC.

 

(c) Preferred Equity Distribution . (i) The Preferred Equity Members shall be entitled to receive, when, as and if declared by the Members in accordance with Section 3.1 of the Operating Agreement, Qualifying Cash available therefor, the Preferred Equity Distribution.

 

C- 3

 

 

(ii) The “ Preferred Equity Distribution ” shall be a dividend on the Preferred Equity Unit, which shall accrue monthly in an amount equal to the lesser of 100% of the Qualifying Cash available for distribution during any month and $6,000.00. All dividends will be cumulative and accrue, whether or not declared, during the period contemplated in Section 3.1 of the Operating Agreement.

 

(iv) For the avoidance of doubt, no Preferred Equity Distribution payments, including, without limitation, payments of any previously declared Preferred Equity Distributions related to the Preferred Equity Unit, will be made to any Preferred Equity Member after termination of employment or appointment within the Company or forfeiture for any other reason of such Preferred Equity Units.

 

Section 3. Right to Terminate Employment. No provision of this Preferred Equity Rider shall limit in any way whatsoever any right that the Company may otherwise have to terminate the employment or appointment of the Preferred Equity Member at any time.

 

Section 4. Withholding Taxes. The Company shall comply with the withholding requirements of any federal, state, local or foreign tax laws applicable to any Preferred Equity Distributions made out of available funds, as defined in and in pursuance with the Operating Agreement. Unless otherwise exempt, Preferred Equity Distributions will be subject to Puerto Rico taxes which will be withheld at source by the Company and deposited with the Puerto Rico Department of Treasury. The Company will make the appropriate allocation of this Puerto Rico income tax withholding and will provide the necessary information to the Preferred Equity Member with respect to this Puerto Rico income tax withholding. The Company shall be required to report the payments of Preferred Equity Distributions to the Puerto Rico Department of Treasury and to the individual, on those forms, on the date and in such manner as the Puerto Rico Department of Treasury may prescribe by regulation, circular letter or other administrative determination or communication of a general character.

 

Section 5. Compliance with Law. The Company shall make reasonable efforts to comply with all applicable federal and state securities laws, as applicable; provided, however, that notwithstanding any other provision of this Preferred Equity Rider, the Company shall not be obligated to issue any restricted or non-restricted Preferred Equity Unit or other limited liability company interests in the Company pursuant to this Preferred Equity Rider if the issuance thereof would result in a violation of any such law.

 

Section 6. Communications. All notices, demands and other communications required or permitted hereunder or designated to be given with respect to the rights or interests covered by the Preferred Equity Rider shall be deemed to have been properly given or delivered when delivered personally or sent by certified or registered mail, as provided in the Operating Agreement and addressed to the parties as follows:

 

C- 4

 

 

If to the Company, at: 53 Calle Las Palmeras, Suite 802, San Juan PR 00901

 

If to the Preferred Equity Member, at: 1213 Calle Luchetti, Apt. 6, San Juan, PR 00907

Either the Company or Preferred Equity Member may change the above designated address by written notice to the other specifying such new address.

 

Section 7. Amendment. This Preferred Equity Rider may be amended, in whole or in part, at any time, in the sole discretion of the Company, provided that such amendment will not adversely affect the rights or obligations with respect to Preferred Equity Interest contemplated herein.

 

Section 8. Integration. The Preferred Equity Unit is granted pursuant to the Operating Agreement and this Preferred Equity Rider. As such, this Preferred Equity Rider and the Operating Agreement of the Company embody the entire agreement and understanding of the parties hereto with respect to the Preferred Equity Interest and Preferred Equity Unit, and supersede any prior understandings or agreements, whether written or oral, with respect to the Preferred Equity Interest and Preferred Equity Unit.

 

Section 9. No Third Party Beneficiary. This Preferred Equity Rider is not intended to confer any rights or benefits on any Persons other than the Company and the Preferred Equity Member.

 

Section 10. Counterparts. This Preferred Equity Rider may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument.

 

Section 11. Severance. In the event that one or more of the provisions of this Preferred Equity Rider shall be invalidated for any reason by a court of competent jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof and the remaining provisions hereof shall continue to be valid and fully enforceable.

 

Section 12. Governing Law. This agreement is made under, and shall be construed in accordance with, the laws of the Commonwealth of Puerto Rico.

 

[Signature page follows]

 

C- 5

 

 

IN WITNESS WHEREOF, this Agreement is executed by the Company on the day and year first above written.

 

IMMUDYNE PR LLC

 

By: /s/ Justin Schreiber   
Name: Justin Schreiber  
Title: President  

 

The undersigned Preferred Equity Member hereby accepts the Preferred Equity Unit subject to the applicable terms and conditions of the Preferred Equity Ride and the Operating Agreement, which he acknowledges to have read and understood, and the terms and conditions hereinabove set forth on the day and year first above written.

 

SEAN FITZPATRICK  
   
   

 

 

C- 6

 

 

SCHEDULE D

  

1. President . The President shall preside at all meetings of the Members, shall be responsible for the general and active management of the business of the Company and shall see that all orders and resolutions of the Members are carried into effect. The President shall perform such other duties as may be assigned or delegated by the Members. The President may execute contracts required to be signed by the Company, so long as the Chief Executive Officer and Chief Operating Officer approve such contract.

 

2. Chief Executive Officer . Oversee, manage and supervise all activities related to operation of the business, including the authority to make any and all decisions with respect to the Company.

 

3. Chief Operating Officer. Oversee contractual commitments and the financial affairs of the Company, including overseeing delivery on the Strategic Additives supplied by Immudyne to the Company.

 

 

D-1

 

Exhibit 10.2  

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of July 23, 2018 (the “Effective Date”), by and between IMMUDYNE PR LLC, a Puerto Rico limited liability company (the “Company”), CONVERSION LABS, INC., a Delaware corporation (the “Parent Company”), and Sean Fitzpatrick, an individual and resident of the Commonwealth of Puerto Rico (the “Executive”).

 

The Company and the Executive are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”

 

WlTNESSETH:

  

WHEREAS, the Company desires to employ, and the Executive agrees to work in the employ of the Company;

 

WHEREAS, the Parties hereto desire to set forth the terms of Executive’s employment with the Company; and

 

NOW, THEREFORE, for and in consideration of the mutual promises, covenants and obligations contained, the Company and Executive hereby agree as follows:

 

1. Employment and Location . The Company hereby employs Executive, and Executive hereby accepts employment by the Company, on the terms and conditions hereinafter set forth. Given the Executive’s personal circumstances, and circumstances at the Company, Executive shall not be required to relocate.

 

2. Executive’s Duties . Executive will serve as Chief Acquisition Officer of the Parent Company and as a Senior Vice President of the Company. Executive’s duties shall include those which are designated or assigned to him from time to time by the President and CEO of the Company, provided those duties are of the type customarily discharged by a person holding the same or similar offices in a company of similar size and operations as the Company. Executive shall devote his entire time, attention and energy to the business of the Company and shall diligently pursue its best interests. The business of the Company includes the management of Legal Simpli Software, a subsidiary of the Company.

 

3. Term of Employment . Subject to the provisions for termination hereof; the original term of this Agreement shall commence as of the date of the Original Effective Date and shall continue for a term of 5 years. Subsections 6(f) through 6(j) and Sections 7 through 20 of this Agreement shall survive termination hereof for any reason whatsoever.

 

4. Compensation . For all services rendered by Executive hereunder on behalf of the Company, and the covenants and agreements of Executive set forth herein (including without limitation the covenant not to compete set forth in Section 8 hereof), the Company agrees to pay to Executive, and Executive agrees to accept, the following compensation:

 

a) An annual salary of $72,000 from the Company; and

  

 

 

 

b) A performance based bonus structure payable in cash to be determined within the first 90 days of Executive’s employment; and

  

c) A Preferred Equity Interest issued by the Company, subject to the terms of the Amended and Restated Operating Agreement for Immudyne PR LLC.

  

d) Subject to the approval of the Parent Company’s board of directors, a ten-year option for 5,000,000 shares of Common Stock of the Parent Company, such shares purchasable or exercisable on a cashless basis at an exercise price of $.30 (thirty cents) per share and shall be subject to the following terms:

 

2,500,000 option shares shall vest in forty-eight (48) equal monthly installments until all 2,500,000 option shares have vested upon the four-year anniversary of this Agreement;

 

500,000 option shares shall vest upon Parent Company achieving at least $20,000,000 in annual revenue;

  

500,000 option shares shall vest upon Parent Company achieving at least $30,000,000 in annual revenue;

 

500,000 option shares shall vest upon Parent Company achieving at least $40,000,000 in annual revenue;

 

500,000 option shares shall vest upon Parent Company achieving at least $50,000,000 in annual revenue;

  

500,000 option shares shall vest upon Parent Company achieving at least $75,000,000 in annual revenue;

 

(d) If the Parent Company is prevented from issuing any of options or the stock due to pending litigation, or for any other reason, then the expiration date(s) will commence (or recommence, if applicable) when the Parent Company’s options or the stock relating thereto are no longer subject to current litigation, or any other contingency prohibiting the Parent Company from issuing said options or stock. All shares resulting from the exercise of options shall have the same rights as all other shares of the Parent Company’s capital stock. Further, if the Parent Company should split its stock prior to the granting or exercise of said options, then the options shall be split in a similar manner and the exercise price shall be adjusted to prevent any dilution or increase in Executive’s interest in the Parent Company’s stock once the options are granted or exercised. Lastly, Executive or his Estate will have the right to assign all his options, and the rights to his options. Executive’s options and the rights to his future options do not terminate with his death. The options may be exercised by his heirs and his assigns and their heirs;

 

(j) Annual paid vacation of four weeks; and

 

  2  

 

 

(k) Prompt reimbursement of all reasonable expenses incurred by Executive in the performance of Executive’s duties during the term of this Agreement, subject to the presentation of appropriate receipts in accordance with the Company’s policies.

 

5. Additional Benefits . Executive shall be entitled to participate in or receive benefits under all benefit plans (including health insurance for himself and his family) and other programs generally available to employees of the Company to the extent that Executive’s position, tenure, salary, age, health and other qualifications make Executive eligible to participate, subject to the rules and regulations applicable thereto.

 

6. Covenants of Executive . For and in consideration of the employment herein contemplated and the consideration paid or promised to be paid by the Company, Executive does hereby covenant, agree and promise that during the term hereof, and thereafter to the extent specifically provided in this Agreement:

 

(a) Executive will not actively engage, directly or indirectly, in any other business or venture that competes with the Company except at the direction or upon the written approval of the CEO of the Company;

 

(b) Executive will not engage, directly or indirectly, in the ownership, management, operation or control of, or employment by, any business of the type and character engaged in by the Company or any of its subsidiaries.

 

(c) Executive will truthfully and accurately make, maintain and preserve all records and reports that the Company may from time to time reasonably request or require;

 

(d) Executive will obey all rules, regulations and reasonable special instructions applicable to Executive, and will be loyal and faithful to the Company at all times, constantly endeavoring to improve Executive’s ability and knowledge of the business in an effort to increase the value of Executive’s services to the mutual benefit of the Parties;

 

(e) Executive will make available to the Company any and all of the information of which Executive has knowledge relating to the business of the Company or any of the Company’s other subsidiaries and will make all suggestions and recommendations which Executive feels will be of benefit to the Company;

 

(f) Executive will fully account for all money, records, goods, wares and merchandise or other property belonging to the Company of which Executive has custody, and will pay over and deliver the same promptly whenever and however he may be reasonably directed to do so;

  

  3  

 

 

(g) Executive recognizes that during the course of Executive’s previous and current employment with the Company, Executive has had and will have access to, and that there has been, and will be disclosed to him, information of a proprietary nature owned by the Company, including but not limited to records, customer and supplier lists and information, pricing information, data, formulae, design information and specifications, inventions, processes and methods, which is of a confidential or trade secret nature, and which has great value to the Company and is a substantial basis and foundation upon which the business of the Company is predicated. Executive acknowledges that except for Executive’s employment and the fulfillment of the duties assigned to Executive, Executive would not have had and would not have access to such information, and Executive agrees that any and all confidential knowledge or information which may have been or may be obtained by or disclosed to Executive in the course of Executive’s employment with the Company, including but not limited to the information hereinabove set forth (collectively, the “Information”), will be held inviolate by Executive, that Executive will conceal the same from any and all other persons, including but not limited to competitors of the Company and its subsidiaries, and that Executive will not impart the Information or any such knowledge acquired by Executive as an officer, director or employee of the Company to anyone, either during Executive’s employment by the Company or thereafter, except to employees or agents of the Company and its subsidiaries on a strict need-to-know basis in the performance of their duties as employees or agents of the Company or one of its subsidiaries. Executive further agrees that during the term of this Agreement and thereafter, Executive will not use the Information in competing with the Company, or in any other manner to Executive’s benefit or to the detriment of the Company or its subsidiaries;

 

(h) Executive agrees that upon termination of Executive’s employment hereunder Executive will immediately surrender and turn over to the Company all books, records, forms, specifications, formulae, data, processes, papers and writings related to the business of the Company, and all other property belonging to the Company, together with all copies of the foregoing, it being understood and agreed that the same are the sole property, directly or indirectly, of the Company;

 

(i) Executive agrees that all ideas, concepts, processes, discoveries, devices, machines, tools, materials, designs, improvements, inventions and other things of value (hereinafter collectively referred to as “intangible rights”), whether patentable or not, which are conceived, made, invented or suggested either by Executive alone or in collaboration with others during the term of Executive’s employment, and whether or not during regular working hours, shall be promptly disclosed in writing to the Company and shall be the sole and exclusive property of the Company. Executive hereby assigns all of Executive’s right, title and interest in and to all such intangible rights to the Company and its successors or assigns. In the event that any of said intangible rights shall be deemed by the Company to be patentable or otherwise able to be registered under any federal, state or foreign law, Executive further agrees that at the request and expense of the Company, he will execute all documents and do all things necessary, advisable or proper to obtain patents therefore or registration thereof; and to vest in the Company full title thereto; and

  

  4  

 

 

(j) Executive understands and acknowledges that the securities of the Company are publicly traded and subject to the Securities Act of 1933 and the Securities Exchange Act of 1934. As a result, Executive acknowledges and agrees that (i) he is required under applicable securities laws to refrain from trading in securities of the Company while in possession of material nonpublic information and to refrain from. disclosing any material nonpublic information to anyone except as permitted by this Agreement in connection with the performance of Executive’s duties hereunder, and (ii) he will communicate to any person to whom he communicates any material nonpublic information that such information is material nonpublic information and that the trading and disclosure restrictions in clause (i) above also apply to such person.

 

7. Termination of Employment. Either the Company or the Executive can terminate the employment at any time and for any reason, with or without notice. In the event of termination, Executive shall be entitled to all option shares vested prior to the date of termination as outlined in Section 4 of this Agreement.

 

8. Covenant Not to Compete . The Executive recognizes that the Company has business good will and other legitimate business interests which must be protected in connection with and in addition to the Information, and therefore, in exchange for access to the Information, the specialized training and instruction which the Company will provide, the Company’s agreement to employ the Executive on the terms and conditions set forth herein, and the promotion and advertisement by the Company of Executive’s skill, ability and value in the Company’s business, the Executive agrees that during the term commencing with the date of employment and ending three years after the date Executive’s employment, Executive will not, without the prior written consent of the Company, engage, directly or indirectly, in any business that competes with the Company or any of its subsidiaries in any territory in which the Company or any of its subsidiaries conducts business (determined as of the last date of Executive’s employment). It is mutually understood and agreed that if any of the provisions relating to the scope, time or territory in this Section 8 are more extensive than is enforceable under applicable laws or are broader than necessary to protect the good will and legitimate business interests of the Company, then the Parties agree that they will reduce the degree and extent of such provisions by whatever minimal amount is necessary to bring such provisions within the ambit of enforceability under applicable law.

 

9. Injunctive Relief . The Parties acknowledge that the remedies at law for breach of Executive’s covenants contained in Sections 6 and 8 of the Agreement are inadequate, and they agree that the Company shall be entitled, at its election, to injunctive relief (without the necessity of posting bond against such breach or attempted breach), and to specific performance of said covenants in addition to any other remedies at law or equity that may be available to the Company.

 

10. Business Opportunities . For as long as the Executive shall be employed by the Company and thereafter with respect to any business opportunities learned about during the time of Executive’s employment by the Company, the Executive agrees that with respect to any future business opportunity or other new and future business proposal which is offered to, or comes to the attention of, the Executive and which is in any way related to or connected with, the business of the Company or its affiliates, the Company shall have the right to take advantage of such business opportunity or other business proposal for its own benefit. The Executive agrees to promptly deliver notice to the Chairman of the Board of Directors or the Chief Executive Officer of the Company in writing of the existence of such opportunity or proposal, and the Executive may take advantage of such opportunity only if the Company does not elect to exercise its right to take advantage of such opportunity and if the pursuit thereof would not otherwise violate any provision of this Agreement.

  

  5  

 

 

11. Right of Offset . To the extent permitted by applicable law, all amounts due and owing to Executive hereunder shall be subject to offset by the Company to the extent of any damages incurred by Executive’s breach of this Agreement. Executive acknowledges and agrees that but for the right of offset contained in this Agreement, the Company would not have hired Executive nor entered into this Employment Agreement.

 

12. Obligations of Executive . The obligations of Executive hereunder are personal and may not be transferred or delegated by Executive.

 

13. Amendment and Waiver . This Agreement may not be changed orally but only by written documents signed by the Party against whom enforcement of any waiver, change, modification, extension or discharge is sought; however, the amount of compensation to be paid to Executive for services to be performed for the Company hereunder may be changed from time to time by the Parties by written agreement without in any other way modifying, changing or affecting this Agreement or the performance by Executive of any of the duties of his employment with the Company. Any such written agreement shall be, and shall be conclusively deemed to be, a ratification and confirmation of this Agreement, except as expressly set forth in such written amendment. The waiver by any Party of a breach of any provision of this Agreement shall not operate as or be construed to be a waiver of any subsequent breach thereof, nor of any breach of any other term or provision of this Agreement.

 

14. Notice . All notices and other communications hereunder shall be in writing and shall be deemed duly delivered (i) three business days after being received by registered or certified mail, return receipt requested, postage prepaid, or (ii) three business days after being sent for next business day delivery, fees prepaid, via a reputable nationwide overnight courier service, in the case of the Company, to its principal office address, and in the case of Executive, to Executive’s residence address as shown on the records of the Company, or may be given by personal delivery thereof.

 

15. Severability . Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be valid and enforceable under applicable law, but if any provision of this Agreement shall be invalid, unenforceable or prohibited by applicable law, then in lieu of declaring such provision invalid or unenforceable, to the extent permitted by law (a) the Parties agree that they will amend such provision to the minimal extent necessary to bring such provision within the ambit of enforceability, and (b) any court of competent jurisdiction may, at the request of either party, revise, reconstruct or reform such provision in a manner sufficient to cause it to be valid and enforceable.

  

  6  

 

 

16. Force Majeure . Neither of the Parties shall be liable to the other for any delay or failure to perform hereunder, which delay or failure is due to causes beyond the control of said Party, including, but not limited to: acts of God; acts of the public enemy; acts of the United States of America or any state, territory or political subdivision thereof or of the District of Columbia; fires; floods; epidemics, quarantine restrictions; strike or freight embargoes. Notwithstanding the foregoing provisions of this Section 16, in every case the delay or failure to perform must be beyond the control and without the fault or negligence of the Party claiming excusable delay.

 

17. Authority to Contract . The Company warrants and represents that it has full authority to enter into this Agreement and to consummate the transactions contemplated hereby and that this Agreement is not in conflict with any other agreement to which the Company is a party or by which it may be bound. The Company hereto further warrants and represents that the individuals executing this Agreement on behalf of the Company have the full power and authority to bind the Company to the terms hereof and have been authorized to do so in accordance with the Company’s corporate organization.

 

18. Mediation . In the event of any dispute arising under or pursuant to this Agreement, the Parties agree to attempt to resolve the dispute in a commercially reasonable fashion before instituting any arbitration or litigation (with the exception of emergency injunctive relief as set forth in Paragraph 9). If the Parties are unable to resolve the dispute within thirty (30) days, then the Parties agree to mediate the dispute with a mutually agreed upon mediator in Houston, Texas. If the Parties cannot agree upon a mediator within ten (10) days after either party shall first request commencement of mediation, each party will select a mediator within five (5) days thereof, and those mediators shall select the mediator to be used. The mediation shall be scheduled within thirty (30) days following the selection of the mediator. If the mediation does not resolve the dispute, then Paragraph 20 shall apply. The Parties further agree that any applicable statute of limitations will be tolled for the period of time from the date mediation is requested until 14 days following the mediation.

 

19. Recovery of Litigation Costs . If any legal action or other proceeding is brought for the enforcement of this Agreement or any agreement or instrument delivered under or in connection with this Agreement, or because of an alleged dispute, breach, default or misrepresentation in connection with any of the provisions of this Agreement, the successful or prevailing Party or Parties shall be entitled to recover reasonable attorneys’ fees and other costs incurred in that action or proceeding, in addition to any other relief to which it or they may be entitled.

 

20. Arbitration . Any and all disputes or controversies whether of law or fact and of any nature whatsoever arising from or respecting this Agreement shall be decided by arbitration by the American Arbitration Association in accordance with its Commercial Rules except as modified herein.

 

(a) The arbitrator shall be elected as follows: in the event the Company and the Executive agree on one arbitrator, the arbitration shall be conducted by such arbitrator. In the event the Company and the Executive do not so agree, the Company and the Executive shall each select one independent, qualified arbitrator and the two arbitrators so selected shall select the third arbitrator (the arbitrator(s) are herein referred to as the “Panel”). The Company reserves the right to object to any individual arbitrator who shall be employed by or affiliated with a competing organization.

   

  7  

 

 

(b) Arbitration shall take place in Houston, Texas or any other location mutually agreeable to the Parties. At the request of either Party, arbitration proceedings will be conducted in the utmost secrecy; in such case all documents, testimony and records shall be received, heard and maintained by the arbitrators in secrecy, available for inspection only by the Company or the Executive and their respective attorneys and their respective experts who shall agree in advance and in writing to receive all such information in secrecy until such information shall become generally known. The Panel shall be able to award any and all relief, including relief of an equitable nature, provided that punitive damages shall not be awarded. The award rendered by the Panel may be enforceable in any court having jurisdiction thereof.

 

(c) Reasonable notice of the time and place of arbitration shall be given to all Parties and any interested persons as shall be required by law.

 

21. Governing Law . This Agreement and the rights and obligations of the Parties shall be governed by and construed and enforced in accordance with the substantive laws (but not the rules governing conflicts of laws) of the Commonwealth of Puerto Rico.

 

22. Multiple Counterparts . This Agreement may be executed in multiple counterparts each of which shall be deemed to be an original but all of which together shall constitute but one instrument.

 

23. Prior Employment Agreements . The Company represents and warrants to Executive, and Executive represents and warrants to the Company, that Executive and the Company have fulfilled all of the terms and conditions of all prior employment agreements to which Executive may be or has been a party.

  

EXECUTED as of the day and year first above set forth.

  

IMMUDYNE PR LLC   EXECUTIVE  
       
By:        
  Justin Schreiber, President   Sean Fitzpatrick  

  

CONVERSION LABS, INC.  
   
By:    
  Robert Kalkstein, CFO  

 

 

8

 

Exhibit 10.3

 

NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES .

 

  Right to Purchase ____________ shares of Common Stock of Conversion Labs, Inc. (subject to adjustment as provided herein)

 

COMMON STOCK PURCHASE WARRANT

 

No.   Issue Date:

 

CONVERSION LABS, INC. , a corporation organized under the laws of the State of Delaware (the “ Company ”), hereby certifies that, for value received, Sean Fitzpatrick , with an address at _________________________________________, (the “ Holder ”), is entitled, subject to the vesting schedule (the “ Vesting Schedule ”) attached hereto as Exhibit B , and the terms set forth below, to purchase from the Company at any time after the Issue Date until 5:00 p.m., E.D.T. on the ten (10) year anniversary of the Issue Date (the “ Expiration Date ”), up to 5,000,0000 fully paid and non-assessable shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”) at a per share purchase price of $0.30. The aforedescribed purchase price per share, as adjusted from time to time as herein provided, is referred to herein as the “ Purchase Price .” The number and character of such shares of Common Stock and the Purchase Price are subject to adjustment as provided herein. The Company may reduce the Purchase Price for some or all of the Warrants, temporarily or permanently, provided such reduction is made as to all outstanding Warrants for all Holders of such Warrants. 

 

As used herein the following terms, unless the context otherwise requires, have the following respective meanings:

 

(a) The term “ Company ” shall mean Conversion Labs, Inc., a Delaware corporation.

 

(b) The term “ Common Stock ” includes (i) the Company’s Common Stock, $0.01 par value per share and (ii) any other securities into which or for which any of the securities described in (i) may be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

 

 

 

 

(c) The term “ Other Securities ” refers to any stock (other than Common Stock) and other securities of the Company or any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement of Common Stock or Other Securities pursuant to Section 5 hereof or otherwise.

 

(d) The term “ Warrant Shares ” shall mean the Common Stock issuable upon exercise of this Warrant.

  

1. Exercise of Warrant .

 

1.1. Number of Shares Issuable upon Exercise . From and after the Issue Date through and including the Expiration Date, the Holder shall be entitled to receive, upon exercise of this Warrant in whole in accordance with the terms of Section 1.2 hereof or upon exercise of this Warrant in part in accordance with Section 1.3 hereof, shares of Common Stock of the Company, subject to the Vesting Schedule and subject to adjustment pursuant to Section 3 hereof.

 

1.2. Full Exercise . This Warrant may be exercised in full by the Holder hereof by delivery to the Company of an original or facsimile copy of the form of subscription attached as Exhibit A hereto (the “ Subscription Form ”) duly executed by such Holder and delivered within two (2) business days thereafter of payment, in cash, wire transfer or by certified or official bank check payable to the order of the Company, in the amount obtained by multiplying the number of shares of Common Stock for which this Warrant is then exercisable by the Purchase Price then in effect. The original Warrant is not required to be surrendered to the Company until it has been fully exercised.

 

1.3. Partial Exercise . This Warrant may be exercised in part (but not for a fractional share) by delivery of a Subscription Form in the manner and at the place provided in Section 1.2 hereof, except that the amount payable by the Holder on such partial exercise shall be the amount obtained by multiplying (a) the number of whole shares of Common Stock designated by the Holder in the Subscription Form by (b) the Purchase Price then in effect. On any such partial exercise, upon the written request of the Holder, provided the Holder has surrendered the original Warrant, the Company, at its expense, will forthwith issue and deliver to or upon the order of the Holder a new Warrant of like tenor, in the name of the Holder hereof or as such Holder (upon payment by such Holder of any applicable transfer taxes) may request, the whole number of shares of Common Stock for which such Warrant may still be exercised.

 

1.4. Fair Market Value . For purposes of this Warrant, the Fair Market Value of a share of Common Stock as of a particular date (the “ Determination Date ”) shall mean:

 

(a) If the Company’s Common Stock is traded on an exchange or on the NASDAQ Global Market, NASDAQ Global Select Market, the NASDAQ Capital Market, the New York Stock Exchange or the NYSE AMEX Equities, then the average of the closing sale prices of the Common Stock for the five (5) trading days immediately prior to (but not including) the Determination Date;

 

  2  

 

 

(b) If the Company’s Common Stock is not traded on an exchange or on the NASDAQ Global Market, NASDAQ Global Select Market, the NASDAQ Capital Market, the New York Stock Exchange or the NYSE AMEX Equities, but is traded on the OTC Bulletin Board or in the over-the-counter market or Pink Sheets, then the average of the closing bid and ask prices reported for the five (5) trading days immediately prior to (but not including) the Determination Date;

 

(c) Except as provided in clause (d) below and Section 3.1 hereof, if the Company’s Common Stock is not publicly traded, then as the Holder and the Company shall mutually agree, or in the absence of such an agreement after good faith efforts of the Company and the Holder to reach an agreement, by arbitration in accordance with the rules then standing of the American Arbitration Association, before a single arbitrator to be chosen from a panel of persons qualified by education and training to pass on the matter to be decided; or

 

(d) If the Determination Date is the date of a liquidation, dissolution or winding up, or any event deemed to be a liquidation, dissolution or winding up pursuant to the Company’s charter, then all amounts to be payable per share to holders of the Common Stock pursuant to the charter in the event of such liquidation, dissolution or winding up, plus all other amounts to be payable per share in respect of the Common Stock in liquidation under the charter, assuming for the purposes of this clause (d) that all of the shares of Common Stock then issuable upon exercise of all of the Warrants are outstanding at the Determination Date.

 

1.5. Company Acknowledgment . The Company will, at the time of the exercise of the Warrant, upon the request of the Holder hereof, acknowledge in writing its continuing obligation to afford to such Holder any rights to which such Holder shall continue to be entitled after such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure shall not affect the continuing obligation of the Company to afford to such Holder any such rights.

 

1.6. Delivery of Stock Certificates, etc. on Exercise . The Company agrees that, provided the purchase price listed in the Subscription Form is received as specified in Section 2 hereof, the shares of Common Stock purchased upon exercise of this Warrant shall be deemed to be issued to the Holder hereof as the record owner of such shares as of the close of business on the date on which delivery of a Subscription Form shall have occurred and payment made for such shares as aforesaid. As soon as practicable after the exercise of this Warrant in full or in part and the payment is made, and in any event within five (5) business days thereafter (“ Warrant Share Delivery Date ”), the Company, at its expense (including the payment by it of any applicable issue taxes), will cause to be issued in the name of, and delivered to, the Holder hereof, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct in compliance with applicable securities laws, a certificate or certificates for the number of duly and validly issued, fully paid and non-assessable shares of Common Stock (or Other Securities) to which such Holder shall be entitled on such exercise, plus, in lieu of any fractional share to which such Holder would otherwise be entitled, cash equal to such fraction multiplied by the then Fair Market Value of one full share of Common Stock, together with any other stock or other securities and property (including cash, where applicable) to which such Holder is entitled upon such exercise pursuant to Section 1 hereof or otherwise. The Company understands that a delay in the delivery of the Warrant Shares after the Warrant Share Delivery Date could result in economic loss to the Holder. As compensation to the Holder for such loss, the Company agrees to pay (as liquidated damages and not as a penalty) to the Holder for late issuance of Warrant Shares upon exercise of this Warrant the proportionate amount of $100 per business day after the Warrant Share Delivery Date for each $10,000 of Purchase Price of Warrant Shares for which this Warrant is exercised which are not timely delivered. The Company shall promptly pay any payments incurred under this Section in immediately available funds upon demand. Furthermore, in addition to any other remedies which may be available to the Holder, in the event that the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder may revoke all or part of the relevant Warrant exercise by delivery of a written notice to such effect to the Company, whereupon the Company and the Holder shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this Warrant, except that the liquidated damages described above shall be payable through the date notice of revocation or rescission is given to the Company.

 

  3  

 

 

1.7. Buy-In . In addition to any other rights available to the Holder, if the Company fails to deliver to a Holder the Warrant Shares as required pursuant to this Warrant, and the Holder or a broker on the Holder’s behalf, purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Warrant Shares which the Holder was entitled to receive from the Company (a “ Buy-In” ), then the Company shall pay in cash to the Holder (in addition to any remedies available to or elected by the Holder) the amount by which (A) the Holder’s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (B) the aggregate Purchase Price of the Warrant Shares required to have been delivered together with interest thereon at a rate of 15% per annum, accruing until such amount and any accrued interest thereon is paid in full (which amount shall be paid as liquidated damages and not as a penalty). For purposes of illustration, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to $10,000 of Purchase Price of Warrant Shares to have been received upon exercise of this Warrant, the Company shall be required to pay the Holder $1,000, plus interest. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In, which shall include evidence of the price at which such Holder had to purchase the Common Stock in an open-market transaction or otherwise.

 

2. Payment of Purchase Price; Cashless Exercise .

 

(a) Payment upon exercise may be made at the written option of the Holder either in (i) cash, wire transfer or by certified or official bank check payable to the order of the Company equal to the applicable aggregate Purchase Price, (ii) by delivery of Common Stock issuable upon exercise of the Warrants in accordance with Section (b) below or (iii) by a combination of any of the foregoing methods, in each case accompanied by delivery of a properly endorsed Subscription Form, for the number of Common Stock specified in such form (as such exercise number shall be adjusted to reflect any adjustment in the total number of shares of Common Stock issuable to the Holder per the terms of this Warrant) and the Holder shall thereupon be entitled to receive the number of duly authorized, validly issued, fully-paid and non-assessable shares of Common Stock (or Other Securities) determined as provided herein. Notwithstanding the immediately preceding sentence, payment upon exercise may be made in the manner described in Section 2(b) below only with respect to Warrant Shares not included for unrestricted public resale in an effective registration statement on the date notice of exercise is given by the Holder.

 

(b) If the Fair Market Value of one share of Common Stock is greater than the Purchase Price (at the date of calculation as set forth below), in lieu of exercising this Warrant for cash, the Holder, eligible at any time, may elect to receive shares equal to the value (as determined below) of this Warrant (or the portion thereof being cancelled) by delivery of a properly endorsed Subscription Form delivered to the Company by any means described in Section 13 hereof, in which event the Company shall issue to the holder a number of shares of Common Stock computed using the following formula:

 

X= Y (A-B)

          A

 

  Where X= the number of shares of Common Stock to be issued to the Holder
     
  Y=

the number of shares of Common Stock purchasable under the Warrant or, if only a portion of the Warrant is being exercised, the portion of the Warrant being exercised (at the date of such calculation)

 

  A=

Fair Market Value

 

  B= Purchase Price (as adjusted to the date of such calculation)

 

For purposes of Rule 144 promulgated under the 1933 Act, it is intended, understood and acknowledged that the Warrant Shares issued in a cashless exercise transaction in the manner described above shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued.

 

  4  

 

 

3. Adjustment for Reorganization, Consolidation, Merger, etc.

 

3.1. Fundamental Transaction . If, at any time while this Warrant is outstanding, (A) the Company effects any merger or consolidation of the Company with or into another entity, (B) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (C) any tender offer or exchange offer (whether by the Company or another entity) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, (D) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, or spin-off) with one or more persons or entities whereby such other persons or entities acquire more than the 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by such other persons or entities making or party to, or associated or affiliated with the other persons or entities making or party to, such stock purchase agreement or other business combination), (E) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of the aggregate Common Stock of the Company, or (F) the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a “ Fundamental Transaction” ), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder, (a) upon exercise of this Warrant, the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “ Alternate Consideration” ) receivable upon or as a result of such reorganization, reclassification, merger, consolidation or disposition of assets by a Holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such event or (b) if the Company is acquired in (1) a transaction where the consideration paid to the holders of the Common Stock consists solely of cash, (2) a “Rule 13e-3 transaction” as defined in Rule 13e-3 under the 1934 Act, or (3) a transaction involving a person or entity not traded on a national securities exchange, the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market, cash equal to the Black-Scholes Value (as defined herein). For purposes of any such exercise, the determination of the Purchase Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Purchase Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Company or surviving entity in such Fundamental Transaction shall issue to the Holder a new warrant consistent with the foregoing provisions and evidencing the Holder’s right to exercise such warrant into Alternate Consideration. The terms of any agreement pursuant to which a Fundamental Transaction is effected include terms requiring any such successor or surviving entity to comply with the provisions of this Section 3.1 and insuring that this Warrant (or any such replacement security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. “ Black-Scholes Value ” shall be determined in accordance with the Black-Scholes Option Pricing Model obtained from the “OV” function on Bloomberg L.P. using (i) a price per share of Common Stock equal to the Volume Weighted Average Price of the Common Stock for the Trading Day immediately preceding the date of consummation of the applicable Fundamental Transaction, (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining term of this Warrant as of the date of such request and (iii) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg L.P. determined as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction.

 

  5  

 

 

3.2. Continuation of Terms . Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred to in this Section 3 hereof, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the Other Securities and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger or the effective date of dissolution following any such transfer, as the case may be, and shall be binding upon the issuer of any Other Securities, including, in the case of any such transfer, the person acquiring all or substantially all of the properties or assets of the Company, whether or not such person shall have expressly assumed the terms of this Warrant as provided in Section 5 hereof.

 

4. RESERVED.

 

5. Extraordinary Events Regarding Common Stock . In the event that the Company shall (a) issue additional shares of Common Stock as a dividend or other distribution on outstanding Common Stock, (b) subdivide its outstanding shares of Common Stock, or (c) combine its outstanding shares of the Common Stock into a smaller number of shares of Common Stock, then, in each such event, the Purchase Price shall, simultaneously with the happening of such event, be adjusted by multiplying the then Purchase Price by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such event, and the product so obtained shall thereafter be the Purchase Price then in effect. The Purchase Price, as so adjusted, shall be readjusted in the same manner upon the happening of any successive event or events described in this Section 5 . The number of shares of Common Stock that the Holder of this Warrant shall thereafter, on the exercise hereof, be entitled to receive shall be adjusted to a number determined by multiplying the number of shares of Common Stock that would otherwise (but for the provisions of this Section 5 ) be issuable on such exercise by a fraction of which (a) the numerator is the Purchase Price that would otherwise (but for the provisions of this Section 5 ) be in effect, and (b) the denominator is the Purchase Price in effect on the date of such exercise.

 

6. Certificate as to Adjustments . In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable on the exercise of the Warrants or in the Purchase Price, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities) outstanding or deemed to be outstanding, and (c) the Purchase Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant Agent (as defined herein) of the Company (appointed pursuant to Section 11 hereof). Holder will be entitled to the benefit of the adjustment regardless of the giving of such notice. The timely giving of such notice to Holder is a material obligation of the Company.

 

  6  

 

 

7. Reservation of Stock, etc. Issuable on Exercise of Warrant; Financial Statements . The Company will at all times reserve and keep available, solely for issuance and delivery on the exercise of the Warrants, all shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrant. This Warrant entitles the Holder hereof, upon written request, to receive copies of all financial and other information distributed or required to be distributed to the holders of the Company’s Common Stock.

 

8. Assignment; Exchange of Warrant . This Warrant shall not be assigned or exchanged.

 

9. Replacement of Warrant . On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation of this Warrant, the Company at its expense, twice only, will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

10. Maximum Exercise . The Holder shall not be entitled to exercise this Warrant on an exercise date, in connection with that number of shares of Common Stock which would be in excess of the sum of (i) the number of shares of Common Stock beneficially owned by the Holder and its Affiliates on an exercise date, and (ii) the number of shares of Common Stock issuable upon the exercise of this Warrant with respect to which the determination of this limitation is being made on an exercise date, which would result in beneficial ownership by the Holder and its Affiliates of more than 4.99% of the outstanding shares of Common Stock on such date. For the purposes of the immediately preceding sentence, beneficial ownership shall be determined in accordance with Section 13(d) of the 1934 Act and Rule 13d-3 thereunder. Subject to the foregoing, the Holder shall not be limited to aggregate exercises which would result in the issuance of more than 4.99%. The Holder may allocate which of the equity of the Company deemed beneficially owned by the Holder shall be included in the 4.99% amount described above and which shall be allocated to the excess above 4.99%. The restriction described in this paragraph may be waived, in whole or in part, upon sixty-one (61) days’ prior notice from the Holder to the Company to increase such percentage.

 

11. Transfer on the Company’s Books . Until this Warrant is transferred on the books of the Company, the Company may treat the registered holder hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

  

  7  

 

 

12. Notices . All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received), or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be: (i) if to the Company, to Conversion Labs, Inc., 1460 Broadway, New York, NY, Attn: _________________, and (ii) if to the Holder, to the address and facsimile number listed on the first paragraph of this Warrant.

 

13. Law Governing This Warrant . This Warrant shall be governed by and construed in accordance with the laws of the State of New York without regard to its principles of conflicts of laws or of any other State. Any action brought by either party hereto against the other concerning the transactions contemplated by this Warrant shall be brought only in the state courts of New York or in the federal courts located in the state of New York. The parties to this Warrant hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens . The Company and the Holder waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Warrant or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform to, such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with this Warrant or any other transaction document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

[-Signature Page Follows-]

 

  8  

 

 

IN WITNESS WHEREOF, the Company has executed this Warrant as of the date first written above.

 

  CONVERSION LABS, INC.
   
  By:          
  Name:   
  Title:  Chief Executive Officer

 

 
  9  

 

 

Exhibit A

 

FORM OF EXERCISE

(to be signed only on exercise of Warrant)

 

TO: CONVERSION LABS, INC.

 

The undersigned, pursuant to the provisions set forth in the attached Warrant (No.____), hereby irrevocably elects to purchase (check applicable box):

 

___ ________ shares of the Common Stock covered by such Warrant; or

___ the maximum number of shares of Common Stock covered by such Warrant pursuant to the cashless exercise procedure set forth in Section 2 of the Warrant.

 

The undersigned herewith makes payment of the full purchase price for such shares at the price per share provided for in such Warrant, which is $______. Such payment takes the form of (check applicable box or boxes):

 

___ $__________ in lawful money of the United States; and/or

___ the cancellation of such portion of the attached Warrant as is exercisable for a total of _______ shares of Common Stock (using a Fair Market Value of $_______ per share for purposes of this calculation); and/or

 

___ the cancellation of such number of shares of Common Stock as is necessary, in accordance with the formula set forth in Section 2 of the Warrant, to exercise this Warrant with respect to the maximum number of shares of Common Stock purchasable pursuant to the cashless exercise procedure set forth in Section 2.

 

After application of the cashless exercise feature as described above, _____________ shares of Common Stock are required to be delivered pursuant to the instructions below.

 

The undersigned requests that the certificates for such shares be issued in the name of, and delivered to __________________________________________, whose address is ___________________________ __________________________________________________________________________________________________.

 

The undersigned represents and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to registration of the Common Stock under the Securities Act of 1933, as amended (the “Securities Act”), or pursuant to an exemption from registration under the Securities Act.

 

Dated:___________________    
   

(Signature must conform to name of holder as

specified on the face of the Warrant)

     
     
     
     
    (Address)

 

  10  

 

 

Exhibit B

 

The Holder will be granted a ten-year warrant to purchase 5,000,000 shares of Common Stock of the Parent Company, such shares purchasable or exercisable on a cashless basis at an exercise price of $.30 (thirty cents) per share and shall be subject to the following terms:

  

2,500,000 option shares shall vest in forty-eight (48) equal monthly installments until all 2,500,000 option shares have vested upon the four-year anniversary of the Holder’s Employment Agreement, dated ____, 2018;  

 

500,000 option shares shall vest upon Conversion Labs, Inc. achieving at least $20,000,000 in annual revenue as reported in the Company’s Annual Report on Form 10-K;

 

500,000 option shares shall vest upon Conversion Labs, Inc. achieving at least $30,000,000 in annual revenue as reported in the Company’s Annual Report on Form 10-K;

 

500,000 option shares shall vest upon Conversion Labs, Inc. achieving at least $40,000,000 in annual revenue as reported in the Company’s Annual Report on Form 10-K;

 

500,000 option shares shall vest upon Conversion Labs, Inc. achieving at least $50,000,000 in annual revenue as reported in the Company’s Annual Report on Form 10-K; and

 

500,000 option shares shall vest upon Conversion Labs, Inc. achieving at least $75,000,000 in annual revenue as reported in the Company’s Annual Report on Form 10-K.

 

The number of shares of Common Stock which have not yet vested pursuant to the above, terminate upon one of the following conditions (i) the Holder’s death, (ii) termination of employment with the Company with or without cause, (iii) termination of employment with the Company with or without reason, or (iv) the Holder’s resignation from the Company.

 

 

11

 

 

Exhibit 99.1

 

Conversion Labs Announces Sean Fitzpatrick as Chief Acquisition Officer  

NEW YORK, July 26, 2018 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (the "Company"), an e-commerce company that builds and scales innovative brands, today announced the appointment of seasoned direct response marketing expert Sean Fitzpatrick to serve as the company's new Chief Acquisition Officer. Mr. Fitzpatrick will oversee Conversion Labs' online customer acquisition efforts for all of the Company's current and future brands.  In addition, Mr. Fitzpatrick will serve as the President of PDFSimpli, Conversion Labs' majority owned online solution for editing, converting, annotating, signing or maintaining PDF documents.  

"I'm truly excited for the opportunity to help Conversion Labs unlock the revenue potential of their health and wellness brands through paid and organic channels," said Sean Fitzpatrick, Conversion Labs' newly appointed Chief Acquisition Officer.  "With the investment in PDFSimpli, the company expanded into the direct to consumer subscription SAAS space, diversified operations and set-up sustainable high margin growth. My team and I will ensure this growth is broadened throughout the company's complete product portfolio."

Mr. Fitzpatrick is a leader in direct response marketing, specializing in the legal, lifestyle and software as a service (SAAS) verticals.  Most recently, he was Head of Customer Acquisition at BOLD, an online company in the career space that connected jobseekers with recruiters. While at BOLD, he created a brand new integrated department that tripled net revenue in four years.  His 20 person customer acquisition team included SEM, SEO, affiliate marketing, social marketing and content marketing specialists for the B2C and B2B markets.

"Sean has had a successful track record in the direct response marketing industry," stated Justin Schreiber, President and CEO of Conversion Labs. "He played an integral role in transforming his prior company, BOLD, into a multi-hundred million dollar business in the career space. He also founded PDFSimpli, which is the newest brand in our product portfolio, to disrupt the fragmented $6 billion online PDF documents space. We are thrilled to have Sean join the leadership team and believe that he will play an integral role in our growth moving forward."

About Conversion Labs

Conversion Labs, Inc. (the "Company") is a technology-driven e-commerce company that builds innovative and proprietary brands. Conversion Labs' scalable and global advertising technology infrastructure leverages the world's largest social media, search and e-commerce platforms (Facebook, Google & Amazon) to rapidly and profitably grow our continually expanding product portfolio. To learn more about our corporate strategy, brands or for investor relations please visit www.conversionlabs.com or email us at info@conversionlabs.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, among other thing, statements regarding the offering, the expected gross proceeds, the expected use of proceeds and the expected closing of the offering. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell its products; the expected benefits and efficacy of the Company's products; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K.

Source: Conversion Labs, Inc.

Exhibit 99.2

 

 

Government of Puerto Rico

 

CERTIFICATE OF AMENDMENT

 

I, LUIS G. RIVERA MARÍN, Secretary of State of the Government of Puerto Rico,

 

CERTIFY: That on July 23, 2018 , at 03:50 PM , “IMMUDYNE PR LLC” , registry number 367400 , performed the following transaction:

 

Name Change

 

Previous Actual
   
IMMUDYNE PR LLC CONVERSION LABS PR LLC

 

 

 

 

 

 

 

 

 

 

 

IN WITNESS WHEREOF , the undersigned by virtue of the authority vested by law, hereby issues this certificate and affixes the Great Seal of the Government of Puerto Rico, in the City of San Juan, Puerto Rico, today, July 23, 2018.

 

 

LUIS G. RIVERA MARÍN

Secretary of State